"Placówka mieszcząca się w centrum Krakowa, obok Pogotowia Ratunkowego powstała w 2008 roku. W SZPITALU, znajdują się dwie sale operacyjne, dwie pooperacyjne i pięć pobytowych – w sumie 16 łóżek. Usługi medyczne świadczone są w ramach umowy z Narodowym Funduszem Zdrowia oraz komercyjnie. W PRZYCHODNI działa kilkanaście poradni specjalistycznych i diagnostycznych oraz punkt pobrań. Usługi medyczne świadczone są w ramach umowy z Narodowym Funduszem Zdrowia oraz komercyjnie."

During the past decade, CenterMed Kraków Śp. z o. o. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CenterMed Kraków Śp. z o. o." #1 sponsor was "Allergan" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Anika Therapeutics, Inc." with 1 trials sponsored, "BlueWind Medical" with 1 trials sponsored and "Coherus Biosciences, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CenterMed Kraków Śp. z o. o." #1 collaborator was "Allergan" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CenterMed Kraków Śp. z o. o." are "Alopecia Areata" (2 trials), "Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials), "Bladder Cancer" (1 trials) and "Osteoarthritis of the Knee" (1 trials). Many other conditions were trialed in "CenterMed Kraków Śp. z o. o." in a lesser frequency.

Most popular intervention types in "CenterMed Kraków Śp. z o. o." are "Drug" (6 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Relamorelin" (2 trials), "Adalimumab" (1 trials), "Apaziquone" (1 trials) and "CHS-1420" (1 trials). Other intervention names were less common.

The vast majority of trials in "CenterMed Kraków Śp. z o. o." are 8 trials for "All" genders.

Currently, there are NaN active trials in "CenterMed Kraków Śp. z o. o.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CenterMed Kraków Śp. z o. o., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CenterMed Kraków Śp. z o. o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".